Gene · 10498
Papers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,160
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Trans-Activation of the Coactivator-Associated Arginine Methyltransferase 1 (Carm1) Gene by the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1. | Genes (Basel) | 2024 | 38927636 | PubTator, text mining | PubMed |
| Protein Arginine Methyltransferase CARM1 in Human Breast Cancer. | Endocrinology | 2024 | 38878278 | PubTator, text mining | PubMed |
| Targeting hematological malignancies with isoxazole derivatives. | Drug Discov Today | 2024 | 38871112 | PubTator, text mining | PubMed |
| ROS-mediated cytoplasmic localization of CARM1 induces mitochondrial fission through DRP1 methylation. | Redox Biol | 2024 | 38838552 | PubTator, text mining | PubMed |
| Research Progress on CARM1 and its Relationship with Colorectal Cancer. | Cancer Invest | 2024 | 38813691 | PubTator, text mining | PubMed |
| Prodrug Approach to Exploit (S)-Alanine Amide as Arginine Mimic Moiety in the Development of Protein Arginine Methyltransferase 4 Inhibitors. | ChemMedChem | 2024 | 38752332 | PubTator, text mining | PubMed |
| A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo. | J Med Chem | 2024 | 38713486 | PubTator, text mining | PubMed |
| Guidelines for the role of autophagy in drug delivery vectors uptake pathways. | Heliyon | 2024 | 38707383 | PubTator, text mining | PubMed |
| Paraspeckles / CARM1 mediates the regulation of OEVs on cell differentiation during in vitro embryonic development of yak. | Theriogenology | 2024 | 38692037 | PubTator, text mining | PubMed |
| CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development. | Nucleic Acids Res | 2024 | 38676947 | PubTator, text mining | PubMed |
| Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity. | Nat Commun | 2024 | 38649367 | PubTator, text mining | PubMed |
| The emerging role of CARM1 in cancer. | Cell Oncol (Dordr) | 2024 | 38619752 | PubTator, text mining | PubMed |
| Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma. | J Med Chem | 2024 | 38574345 | PubTator, text mining | PubMed |
| PRMT4 interacts with NCOA4 to inhibit ferritinophagy in cisplatin-induced acute kidney injury. | FASEB J | 2024 | 38568836 | PubTator, text mining | PubMed |
| Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality. | Endocrinol Metab (Seoul) | 2024 | 38509667 | PubTator, text mining | PubMed |
| SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer. | Cell Rep | 2024 | 38507413 | PubTator, text mining | PubMed |
| CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A. | Protein Cell | 2024 | 38476024 | PubTator, text mining | PubMed |
| Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy. | Eur J Med Chem | 2024 | 38460270 | PubTator, text mining | PubMed |
| Androgen receptor cofactors: A potential role in understanding prostate cancer. | Biomed Pharmacother | 2024 | 38417290 | PubTator, text mining | PubMed |
| NEAT1 repression by MED12 creates chemosensitivity in p53 wild-type breast cancer cells. | FEBS J | 2024 | 38380720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10498/papers?page=7